Cryptocurrency exchanges in the U.S. will be shunned by investors and the Biden administration will force the multi-trillion dollar sector of the future of money away from America, according to the chief
By Lukman Otunuga, Senior Research Analyst at FXTM The mood across European markets darkened on Tuesday as surging Covid-19 cases on the continent dented risk sentiment. Austria reintroduced a national lockdown on
Cypriot EU Health Commissioner Stella Kyriakides said the new COVID-19 outbreak surging across Europe is being driven by the unvaccinated when vaccines are the only effective response. “What we are seeing in
The European Medicines Agency (EMA) is fast-tracking evaluation of the Johnson&Johnson (Janssen) COVID-19 vaccine booster dose to be given two months after the first shot to people aged 18 and older. EMA’s
Moody’s Investors Service has upgraded the long-term senior secured ratings of the state-owned Israel Electric Corporation to Baa1 from Baa2. The upgrade reflects significant reductions in IEC’s leverage and improvements in the
By Hussein Sayed, Chief Market Strategist at Exinity Group The European single currency is struggling to find support, having fallen more than 7.5% so far in 2021. The euro is now the
Turkey’s lira recouped 2.4% of its value on Friday after hitting another low, as the currency crashed when the country’s Central Bank announced that interest rates would be slashed again. The Turkish
Financial regulators must work together on an international framework to stamp out potential ‘greenwashing’ as capital inflows increase, affirms the CEO of one of the world’s largest independent financial advisory, asset management
Developments in the Eastern Mediterranean will be discussed during the first quadrilateral meeting of Foreign ministers from Cyprus, Greece, Egypt and France in Athens. Cypriot Foreign Minister Nikos Christodoulides is in Athens
The European Medicines Agency (EMA) has started evaluating an application for conditional marketing authorisation for Novavax’s COVID-19 vaccine, Nuvaxovid, the agency announced. The EU assessment will proceed under an accelerated timeline. An
